UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057906
Receipt number R000066183
Scientific Title A Randomized Controlled Trial of Internet-based Cognitive Behavioral Therapy for Chronic Non-cancer Pain
Date of disclosure of the study information 2025/05/20
Last modified on 2025/05/20 14:17:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Effectiveness of Internet-based Cognitive Behavioral Therapy for Chronic Non-Cancer Pain

Acronym

Internet-based Cognitive Behavioral Therapy for Chronic Non-Cancer Pain

Scientific Title

A Randomized Controlled Trial of Internet-based Cognitive Behavioral Therapy for Chronic Non-cancer Pain

Scientific Title:Acronym

Internet-based Cognitive Behavioral Therapy for Chronic Non-Cancer Pain

Region

Japan


Condition

Condition

Chronic non-cancer pain

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the effectiveness of internet-based cognitive behavioral therapy (iCBT) for patients with chronic non-cancer pain.Assessments include conventional clinical outcome measures related to pain, molecular biological analysis using exosomes, brain activity measured by electroencephalogram and functional neuroimaging with functional Magnetic Resonance Imaging (fMRI). The study aims to determine whether there are differences in treatment effects and prognosis between the intervention and control groups, and whether these outcomes are associated with brain function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in patient self-reported pain intensity measured by the Visual Analogue Scale (VAS, 0 - 100)

Key secondary outcomes

1. Changes in psychological state and pain-related physical impairment
2. Changes in electroencephalogram (EEG) and functional Magnetic Resonance Imaging (fMRI)
3. Changes in exosomes


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Common procedures for both intervention and control groups:
1. The internet-based cognitive behavioral therapy (iCBT) used in this study consists of eight sessions, conducted weekly or biweekly over a maximum of four months, based on an original standardized manual.
2. All sessions are conducted in a private room within the Pain Management Center in our hospital, with a trained therapist.
3. In this study, participants in both groups will undergo a total of three evaluations. Evaluation refers to the obtaining pain-related questionnaires, electroencephalogram (EEG), Magnetic Resonance Imaging (MRI), and blood sampling. These procedures are collectively referred to as evaluation hereafter.

Intervention group:
1. The first evaluation is conducted after obtaining informed consent for enrollment of the study.
2. Participants then undergo the iCBT sessions.
3. The second evaluation is conducted after completing all the iCBT sessions.
4. The third evaluation is conducted after a four-month follow-up period.

Interventions/Control_2

Common procedures for both intervention and control groups:
1. The internet-based cognitive behavioral therapy (iCBT) used in this study consists of eight sessions, conducted weekly or biweekly over a maximum of four months, based on an original standardized manual.
2. All sessions are conducted in a private room within the Pain Management Center in our hospital, with a trained therapist.
3. In this study, participants in both groups will undergo a total of three evaluations. Evaluation refers to the obtaining pain-related questionnaires, electroencephalogram (EEG), Magnetic Resonance Imaging (MRI), and blood sampling. These procedures are collectively referred to as evaluation hereafter.

Control group:
1. The first evaluation is conducted after obtaining informed consent for enrollment of the study.
2. The second evaluation is conducted after a four-month waiting period.
3. Participants then undergo the iCBT sessions.
4. The third evaluation is conducted after completing the iCBT sessions.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Aged between 20 and 74 years.
2. Patients with chronic pain lasting for more than three months and with a pain intensity of 4 or higher on the Numerical Rating Scale (NRS).
3. Patients who have not responded to standard pharmacological treatment and nerve block therapy for at least two months.
4. Patients diagnosed with primary chronic pain through a multidisciplinary conference at Interdisciplinary Pain Center in our hospital.
5. Patients who can provide written informed consent based on their own free will.

Key exclusion criteria

1. Patients who are eligible for surgical treatment.
2. Patients with a history of anomalies of the central nervous system
3. Patients with severe psychiatric disorders or having conditions such as epilepsy.
4. Patients with cognitive impairment.
5. Patients who do not have a device to access to internet web site.
6. Patients who are unable to undergo MRI (e.g., due to claustrophobia or presence of metal in the body).
7. Patients who are unable to complete all eight sessions within a four-month period.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Shizuko
Middle name
Last name Kosugi

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-5363-3107

Email

kosugi.z6@keio.jp


Public contact

Name of contact person

1st name Morihiko
Middle name
Last name Kawate

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

TEL

03-5363-3107

Homepage URL


Email

morihikok2@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 05 Month 04 Day

Date of IRB

2025 Year 05 Month 20 Day

Anticipated trial start date

2025 Year 06 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 19 Day

Last modified on

2025 Year 05 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066183